These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
459 related articles for article (PubMed ID: 36555579)
1. The Impact of Cytokines in Coronary Atherosclerotic Plaque: Current Therapeutic Approaches. Tsioufis P; Theofilis P; Tsioufis K; Tousoulis D Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555579 [TBL] [Abstract][Full Text] [Related]
2. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia. Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472 [TBL] [Abstract][Full Text] [Related]
3. The Role of Colchicine in Acute Coronary Syndromes. Vaidya K; MartÃnez G; Patel S Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392 [TBL] [Abstract][Full Text] [Related]
4. Hegemony of inflammation in atherosclerosis and coronary artery disease. Attiq A; Afzal S; Ahmad W; Kandeel M Eur J Pharmacol; 2024 Mar; 966():176338. PubMed ID: 38242225 [TBL] [Abstract][Full Text] [Related]
5. Why Colchicine Should Be Considered for Secondary Prevention of Atherosclerosis: An Overview. Nidorf SM; Thompson PL Clin Ther; 2019 Jan; 41(1):41-48. PubMed ID: 30591286 [TBL] [Abstract][Full Text] [Related]
6. Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes. Dimitroglou Y; Aggeli C; Theofilis P; Tsioufis P; Oikonomou E; Chasikidis C; Tsioufis K; Tousoulis D Life (Basel); 2023 Jul; 13(8):. PubMed ID: 37629526 [TBL] [Abstract][Full Text] [Related]
7. The Role of Colchicine in Coronary Artery Disease. Butt AK; Cave B; Maturana M; Towers WF; Khouzam RN Curr Probl Cardiol; 2021 Mar; 46(3):100690. PubMed ID: 32994053 [TBL] [Abstract][Full Text] [Related]
8. Role of vascular inflammation in coronary artery disease: potential of anti-inflammatory drugs in the prevention of atherothrombosis. Inflammation and anti-inflammatory drugs in coronary artery disease. Moreira DM; da Silva RL; Vieira JL; Fattah T; Lueneberg ME; Gottschall CA Am J Cardiovasc Drugs; 2015 Feb; 15(1):1-11. PubMed ID: 25369900 [TBL] [Abstract][Full Text] [Related]
9. The Role of Colchicine in Atherosclerotic Cardiovascular Disease. Kurup R; Galougahi KK; Figtree G; Misra A; Patel S Heart Lung Circ; 2021 Jun; 30(6):795-806. PubMed ID: 33461916 [TBL] [Abstract][Full Text] [Related]
11. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation. MartÃnez GJ; Celermajer DS; Patel S Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570 [TBL] [Abstract][Full Text] [Related]
12. Reducing residual cardiovascular risk in Europe: Therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid. Chapman MJ; Zamorano JL; Parhofer KG Pharmacol Ther; 2022 Sep; 237():108172. PubMed ID: 35304222 [TBL] [Abstract][Full Text] [Related]
14. The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis. Kottoor SJ; Arora RR J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):483-493. PubMed ID: 29783850 [TBL] [Abstract][Full Text] [Related]
15. Targeting the residual cardiovascular risk by specific anti-inflammatory interventions as a therapeutic strategy in atherosclerosis. Hafiane A; Daskalopoulou SS Pharmacol Res; 2022 Apr; 178():106157. PubMed ID: 35257900 [TBL] [Abstract][Full Text] [Related]